BioCardia, Inc.
BCDA
$2.23
-$0.02-0.89%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -99.36% | -87.84% | -87.54% | 0.71% | -65.49% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -99.36% | -87.84% | -87.54% | 0.71% | -65.49% |
| Cost of Revenue | -74.12% | -81.69% | -52.93% | -43.94% | -27.11% |
| Gross Profit | 72.18% | 81.28% | 50.52% | 46.14% | 20.34% |
| SG&A Expenses | -11.99% | -16.45% | -15.33% | -10.35% | -2.59% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -22.27% | -33.51% | -40.41% | -32.91% | -19.07% |
| Operating Income | 18.80% | 31.29% | 38.27% | 34.00% | 13.86% |
| Income Before Tax | 18.83% | 31.33% | 38.36% | 34.21% | 14.45% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 18.83% | 31.33% | 38.36% | 34.21% | 14.45% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 18.83% | 31.33% | 38.36% | 34.21% | 14.45% |
| EBIT | 18.80% | 31.29% | 38.27% | 34.00% | 13.86% |
| EBITDA | 18.75% | 31.37% | 38.43% | 34.12% | 13.90% |
| EPS Basic | 63.39% | 59.65% | 55.01% | 46.96% | 27.99% |
| Normalized Basic EPS | 63.39% | 59.64% | 55.01% | 46.95% | 27.99% |
| EPS Diluted | 56.25% | 53.58% | 55.01% | 46.96% | 27.99% |
| Normalized Diluted EPS | 63.39% | 59.64% | 55.01% | 46.95% | 27.99% |
| Average Basic Shares Outstanding | 133.01% | 94.22% | 46.89% | 27.00% | 21.18% |
| Average Diluted Shares Outstanding | 133.01% | 94.22% | 46.89% | 27.00% | 21.18% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |